Lv2
130 积分 2025-12-29 加入
Therapeutic bispecific antibody formats: a patent applications review (1994-2017)
7天前
已完结
Recent Advances in the Immunopathology of Axial Spondyloarthritis: with and without HLA-B27
9天前
已完结
Axial spondyloarthritis: Moving beyond cytokine based therapies to cellular targets and advanced therapeutics
9天前
已关闭
The making of multispecific immunoglobulins – a clinical perspective
19天前
已完结
Cis interactions between CD2 and its ligands on T cells are required for T cell activation
20天前
已完结
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
30天前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2个月前
已完结
A modular platform for Sterically Masked Activated Cytokines (SMACks)
2个月前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
2个月前
已完结
Anti-4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
2个月前
已完结
皖公网安备34019202002308
